SOSV — 2024 Investments
8 investments dated 2024 · listed companies and verified rows first · show all
Afynia develops diagnostic tools focused on women's health, with an emphasis on endometriosis detection through diagnostic biomarkers.
BiotechDigital HealthFemTechMedical Devices
Dr. Lauren Foster(Co-Founder & Chief Executive Officer)Dr. Jocelyn Wessels(Co-Founder & Chief Scientific Officer)Dr. Jake Prigoff(Chief Medical Officer)Darren Farry(Chief Financial Officer)
Co-investorsGaingelsImpact America Fund
Unlocking post-translational protein modification using chemical biology and computational approaches to develop drugs for previously undruggable oncology targets.
BiotechCambridge, US
Xu Wu(Director)
BoardDavid Fallace(Director)Seth Lieblich(Director)inDrew King(Executive Officer)Milenko Cicmil(Executive Officer, Director)
Board seatMichael Aberman· per SEC Form D · $70.2M raise · filed Dec 2025
Co-investors8VCCure Ventures
Alexandria, US
Andrew Magyar(Executive Officer, Director)Elizabeth Onderko(Executive Officer, Director, Promoter)
BoardPae Wu(Director)inDanielle Joseph(Director)Douglas Cameron(Director)
Co-investorsBlue Ivy VenturesFirst Bight VenturesGS FuturesClosed Loop PartnersThe E14 Fund
Hyperlume develops copper interconnect and Active Electrical Cable (AEC) connectivity solutions supporting data rates from 100G up to 1.6T for data centers and AI deployments.
Deep TechHardwareSemiconductorsOttawa
Charles Lesperance(Director)Hossein Fariborzi(President, Treasurer and Chief Technology Officer.)Mohsen Asad(Chief Executive Officer and Corporate Secretary.)
Co-investorsArcTern VenturesLG Technology VenturesUCeed Funds
Level Zero Health develops electrochemical and microfluidic biosensor platforms for point-of-care and continuous diagnostic devices.
BiotechHealthtechMedical DevicesDover, US
Ula Rustamova(CEO)inIrene Jia(CTO)inUlviyya Rustamova(Executive Officer, Director)Yiran Jia(Director)
BoardPhilip Kneis(Director)in
Co-investorsAnorak VenturesBlack Jays VenturesEntrepreneur FirstSamos InvestmentsTranspose Platform ManagementUnruly Capital+1 more
OneSkin develops topical skincare products built around OS-01, a proprietary peptide the company says reduces cellular senescence in skin to address visible signs of aging such as wrinkles and hyperpigmentation.
BiotechDirect to ConsumerLongevitySan Francisco, US
Carolina Reis de Oliveira(Executive Officer, Director)Alessandra Zonari(Director)Carolina Reis Oliveira(Founder)inAlessandra Zonari Scheel(Founder)inEdgar Andres Ochoa Cruz(Executive Officer, Director)
BoardTara Poseley(Director)
Co-investorsAble PartnersMetaplanetPLUS CapitalSelva VenturesUnilever VenturesPrelude Growth Partners
Samphire Neuro makes the Nettle Headband, a medical-grade wearable that uses neurostimulation to manage mood and chronic pain symptoms linked to hormonal changes across the menstrual cycle.
Digital HealthFemTechMedical Devices
Emilė Radytė(CEO)
Co-investorsAfterWork VenturesAlberts Impact VenturesAngel AcademeCVX VenturesFirstpickFortify Ventures+3 more
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.
BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US
Harshal Chokhawala(Founder & CEO)
Co-investorsAccelr8Breakout LabsBreakout VenturesCavallo VenturesDudley FundFreshTracks Capital+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.